speb/financial-data huggingface dataset:
Financial ratios for CARRARO.NS — quarterly report dated 2025-03-31
Total revenue: 51937573.065232635
Gross profit: 15356324.526537292
Operating income: 3949497.3111994388
Net income: 2773790.0397474864
Capital expenditures: 0
Depreciation & amortization: 1345803.1330371755
Net tangible assets: 50505377.601122275
Owner earnings: 4119593.172784662
Return on net tangible assets (%): 8.156741654958186
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.5686777920410786
P/E ratio: 18.28588485400009
Shares outstanding: 56851538
Book value: 53550502.68880056
P/B ratio: 3.7886632415574018
Market cap (USD): 202884821.10397947
Debt to equity: 0.41630227628468075
Current ratio: 1.515960463509956
Quick ratio: 0.8567453233028285
Effective tax rate (%): 25.978037062457105
Interest coverage ratio: 6.342031162004882
COGS to revenue (%): 70.43311109810612
Buyback yield (%): 0
Retained earnings: 38267243.39490297
Inventory turnover: 1.0475087371620626
Receivables turnover: 1.5253204974147343
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.163159760853884
Rule of 40 score: 0
Financial ratios for CARRARO.NS — annual report dated 2025-03-31
Total revenue: 211310965.63011456
Gross profit: 57736965.16249707
Operating income: 14662263.268646246
Net income: 10303483.75029226
Capital expenditures: 6009352.349777881
Operating cash flow: 8918283.843815759
Depreciation & amortization: 5283610.007014262
Net tangible assets: 50505377.601122275
Owner earnings: 9577741.40752864
Return on net tangible assets (%): 18.96380516778042
Capex to operating income (%): 40.98516197446999
Buffett classification: The Good
Stock price: 3.5686777920410786
P/E ratio: 19.690895431190892
Shares outstanding: 56851538
Book value: 53550502.68880056
P/B ratio: 3.7886632415574018
Market cap (USD): 202884821.10397947
Debt to equity: 0.41630227628468075
Current ratio: 1.515960463509956
Quick ratio: 0.8567453233028285
Effective tax rate (%): 25.725794898156966
Interest coverage ratio: 5.553779391577735
COGS to revenue (%): 72.67677756791775
SG&A to revenue (%): 0.8808588844372007
Free cash flow (dilution-adjusted): 2842997.4281038106
Buyback yield (%): 0
Retained earnings: 38267243.39490297
Inventory turnover: 4.397611172855211
Receivables turnover: 6.205853069015951
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.167909672213323
FCF margin (%): 1.345409321104653
Revenue growth (%): -0.9879090910890105
Rule of 40 score: 0.35750023001564246
Financial ratios for CARRARO.NS — quarterly report dated 2025-06-30
Total revenue: 57679148.139480464
Gross profit: 15982915.984086124
Operating income: 4285396.676807864
Net income: 3407442.078165224
Capital expenditures: 0
Depreciation & amortization: 1312426.8663702318
Owner earnings: 4719868.944535456
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.272876199391528
P/E ratio: 21.993853067960163
Shares outstanding: 56851538
Market cap (USD): 299771121.61900306
Effective tax rate (%): 24.24163588115927
Interest coverage ratio: 7.072808033989958
COGS to revenue (%): 72.28995833045934
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.054761967865764
Rule of 40 score: 11.054761967865764
Financial ratios for CARRARO.NS — quarterly report dated 2025-09-30
Total revenue: 66094137.542277336
Gross profit: 16888162.34498309
Operating income: 4611837.655016911
Net income: 3574633.5963923335
Capital expenditures: 0
Depreciation & amortization: 1299436.3021420517
Net tangible assets: 52703720.40586246
Owner earnings: 4874069.8985343855
Return on net tangible assets (%): 9.248056609666254
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.147688838782413
P/E ratio: 29.997750707156115
Shares outstanding: 56851538
Book value: 55550281.84892897
P/B ratio: 5.268272597177771
Market cap (USD): 292654027.6302142
Debt to equity: 0.37201434454093607
Current ratio: 1.5134726259112783
Quick ratio: 0.9129997141087339
Effective tax rate (%): 25.440906739406476
Interest coverage ratio: 7.8501247361351
COGS to revenue (%): 74.4483202701896
Buyback yield (%): 0
Inventory turnover: 1.4430668108222489
Receivables turnover: 1.806652121122472
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.040688668337293
Revenue growth (%): 14.5893094371776
Rule of 40 score: 14.5893094371776
Financial ratios for CARRARO.NS — quarterly report dated 2025-12-31
Total revenue: 63449482.00958004
Gross profit: 17342207.864542723
Operating income: 4851843.600311909
Net income: 3126434.2207864546
Capital expenditures: 0
Depreciation & amortization: 1300211.6519995544
Owner earnings: 4426645.872786009
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.896736103375293
P/E ratio: 26.023188277414636
Shares outstanding: 56851538
Market cap (USD): 335238516.6570124
Effective tax rate (%): 23.981581798483205
Interest coverage ratio: 10.098539299791328
COGS to revenue (%): 72.66769197276619
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.001346611120593
Rule of 40 score: -4.001346611120593
Financial ratios for CCIF — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.58
Shares outstanding: 21198622
Market cap (USD): 97089688.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIF — annual report dated 2022-09-30
Total revenue: -1409059
Net income: -3128732
Capital expenditures: 0
Operating cash flow: 2258082
Net tangible assets: 107829465
Owner earnings: -3128732
Return on net tangible assets (%): -2.901555711140735
Buffett classification: The Gruesome
Stock price: 4.31
Shares outstanding: 21198622
Book value: 107829465
P/B ratio: 0.8473199864248607
Market cap (USD): 91366060.82
Debt to equity: 0.06914007224277706
Free cash flow (dilution-adjusted): 2258082
Buyback yield (%): 0
Retained earnings: 73478
Receivables turnover: -0.5265722887333945
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIF — annual report dated 2023-09-30
Total revenue: -6657472
Net income: -11822059
Capital expenditures: 0
Operating cash flow: 4400674
Net tangible assets: 98750740
Owner earnings: -11822059
Return on net tangible assets (%): -11.971615605108376
Buffett classification: The Gruesome
Stock price: 4.88
Shares outstanding: 21198622
Book value: 98750740
P/B ratio: 1.0475797483644171
Market cap (USD): 103449275.36
Debt to equity: 0
Free cash flow (dilution-adjusted): 4400674
Buyback yield (%): 0
Retained earnings: -13318304
Receivables turnover: -1.7637645079016717
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIF — annual report dated 2024-09-30
Total revenue: 7937298
Net income: 5566742
Capital expenditures: 0
Operating cash flow: -74617028
Net tangible assets: 117613003
Owner earnings: 5566742
Return on net tangible assets (%): 4.733100811991001
Buffett classification: The Gruesome
Stock price: 5.72
P/E ratio: 21.782241361284573
Shares outstanding: 21198622
Book value: 117613003
P/B ratio: 1.0309754427407996
Market cap (USD): 121256117.83999999
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 28.301998992604283
Free cash flow (dilution-adjusted): -74617028
Buyback yield (%): 0
Retained earnings: -7697008
Receivables turnover: 1.2890285974313613
Capitalized R&D asset: 0
FCF margin (%): -940.0809696196363
Rule of 40 score: -940.0809696196363
Financial ratios for CCIF — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 117613003
Buffett classification: The Gruesome
Stock price: 5.72
Shares outstanding: 21198622
Book value: 117613003
P/B ratio: 1.0309754427407996
Market cap (USD): 121256117.83999999
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -7697008
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIF — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 131969284
Buffett classification: The Gruesome
Stock price: 5.09
Shares outstanding: 21198622
Book value: 131969284
P/B ratio: 0.8176219701245026
Market cap (USD): 107900985.98
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -20388440
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIF — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 129913622
Buffett classification: The Gruesome
Stock price: 4.84
Shares outstanding: 21198622
Book value: 129913622
P/B ratio: 0.7897657605143209
Market cap (USD): 102601330.48
Debt to equity: 0.05195759995052713
Buyback yield (%): 0
Retained earnings: -21716073
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIF — annual report dated 2025-09-30
Total revenue: -3479050
Net income: -6002869
Capital expenditures: 0
Operating cash flow: -33004180
Net tangible assets: 129913622
Owner earnings: -6002869
Return on net tangible assets (%): -4.620661719369198
Buffett classification: The Gruesome
Stock price: 4.84
Shares outstanding: 21198622
Book value: 129913622
P/B ratio: 0.7897657605143209
Market cap (USD): 102601330.48
Debt to equity: 0.05195759995052713
Free cash flow (dilution-adjusted): -33004180
Buyback yield (%): 0
Retained earnings: -21716073
Receivables turnover: -0.20296892776481099
Capitalized R&D asset: 0
Revenue growth (%): -143.8316666452488
Rule of 40 score: -143.8316666452488
Financial ratios for CEL.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.16541353383458646
Shares outstanding: 2438835717
Market cap (USD): 403416434.39097744
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEL.AX — annual report dated 2022-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1310344827586207
Shares outstanding: 2438835717
Market cap (USD): 319571576.71034485
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEL.AX — annual report dated 2022-12-31
Operating income: -1929808.1081081082
Net income: 16679033.783783784
Capital expenditures: 76514.18918918919
Depreciation & amortization: 46807.43243243243
Net tangible assets: 100836001.35135135
Owner earnings: 16649327.027027026
Return on net tangible assets (%): 16.51129239944212
Buffett classification: The Gruesome
Stock price: 0.11486486486486487
P/E ratio: 16.7957292186298
Shares outstanding: 2438835717
Book value: 100836001.35135135
P/B ratio: 2.778140062146133
Market cap (USD): 280136535.0608108
Debt to equity: 0.08367798470090068
Current ratio: 0.7731722578397031
Quick ratio: 0.7731722578397031
Effective tax rate (%): 7.366393920376056
Interest coverage ratio: -2.512819610458395
Free cash flow (dilution-adjusted): -17092211.486486487
Buyback yield (%): 0.04802363844742821
Retained earnings: 31188668.91891892
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.805472751013592
Rule of 40 score: 0
Financial ratios for CEL.AX — annual report dated 2023-12-31
Operating income: -2865587.671232877
Net income: 36891643.83561644
Capital expenditures: 37490.41095890411
Depreciation & amortization: 119860.27397260274
Net tangible assets: 87266822.60273972
Owner earnings: 36974013.69863014
Return on net tangible assets (%): 42.36892394598236
Buffett classification: The Gruesome
Stock price: 0.04794520547945206
P/E ratio: 3.169565446940132
Shares outstanding: 2438835717
Book value: 87266822.60273972
P/B ratio: 1.3399190676906894
Market cap (USD): 116930479.5821918
Debt to equity: 0.11248435272451807
Current ratio: 0.3037528747447533
Quick ratio: 0.3037528747447533
Effective tax rate (%): -7.639400155622267
Interest coverage ratio: -0.9991335883532113
Free cash flow (dilution-adjusted): -17388269.17808219
Buyback yield (%): 0.4010256646104852
Retained earnings: 68507554.79452056
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.223742007928306
Rule of 40 score: 0
Financial ratios for CEL.AX — annual report dated 2024-12-31
Operating income: -3186877.0186335403
Net income: 46334296.89440993
Capital expenditures: 5323.60248447205
Depreciation & amortization: 140940.37267080744
Net tangible assets: 126111965.2173913
Owner earnings: 46469913.66459627
Return on net tangible assets (%): 36.848140130471855
Buffett classification: The Gruesome
Stock price: 0.031055900621118012
P/E ratio: 1.6346474368864954
Shares outstanding: 2438835717
Book value: 126111965.2173913
P/B ratio: 0.6005793306592628
Market cap (USD): 75740239.6583851
Debt to equity: 0.094151616154321
Current ratio: 0.05251689560291558
Quick ratio: 0.05251689560291558
Effective tax rate (%): -4.25858849590242
Interest coverage ratio: -1.1451487090028878
Free cash flow (dilution-adjusted): -12233036.645962732
Buyback yield (%): 0.13075911500602316
Retained earnings: 108459160.2484472
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5081215598502205
Rule of 40 score: 0
Financial ratios for CEL.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 126111965.2173913
Buffett classification: The Gruesome
Stock price: 0.031055900621118012
Shares outstanding: 2438835717
Book value: 126111965.2173913
P/B ratio: 0.6005793306592628
Market cap (USD): 75740239.6583851
Debt to equity: 0.094151616154321
Current ratio: 0.05251689560291558
Quick ratio: 0.05251689560291558
Buyback yield (%): 0
Retained earnings: 108459160.2484472
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.42
Shares outstanding: 166419451
Market cap (USD): 12551354994.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNX — annual report dated 2022-12-31
Total revenue: 1006090000
Gross profit: 721905000
Operating income: 268665000
Net income: 215525000
Capital expenditures: 19667000
Operating cash flow: 243406000
Depreciation & amortization: 19621000
Net tangible assets: 1183350000
Owner earnings: 215479000
Return on net tangible assets (%): 18.209236489626907
Capex to operating income (%): 7.320268736158413
Buffett classification: The Great
Stock price: 45.92
P/E ratio: 35.45751625064378
Shares outstanding: 166419451
Book value: 1438394000
P/B ratio: 5.312856692894993
Market cap (USD): 7641981189.92
Debt to equity: 0.027636377793566994
Current ratio: 3.8234864789992966
Quick ratio: 3.170983655464871
Effective tax rate (%): 14.02899938171882
COGS to revenue (%): 28.246478943235694
R&D to revenue (%): 14.027870270055361
SG&A to revenue (%): 31.02177737578149
Free cash flow (dilution-adjusted): 169234000
Buyback yield (%): 2.6735737097795558
Retained earnings: 528179000
Inventory turnover: 2.3202563683866755
Receivables turnover: 7.884965045926204
Capitalized R&D asset: 141133000
ROCI (R&D-adjusted, %): 18.97678952411593
FCF margin (%): 16.82096035145961
Rule of 40 score: 16.82096035145961
Financial ratios for CGNX — annual report dated 2023-12-31
Total revenue: 837547000
Gross profit: 601241000
Operating income: 122702000
Net income: 113234000
Capital expenditures: 23077000
Operating cash flow: 112916000
Depreciation & amortization: 21880000
Net tangible assets: 998619000
Owner earnings: 112037000
Return on net tangible assets (%): 11.219193706508689
Capex to operating income (%): 18.80735440335121
Buffett classification: The Great
Stock price: 40.95
P/E ratio: 60.18401291529047
Shares outstanding: 166419451
Book value: 1504752000
P/B ratio: 4.528903446182494
Market cap (USD): 6814876518.450001
Debt to equity: 0.05223518559869002
Current ratio: 4.470497221563825
Quick ratio: 3.4020173290142477
Effective tax rate (%): 16.338623400419657
COGS to revenue (%): 28.214058434929623
R&D to revenue (%): 16.64384207692225
SG&A to revenue (%): 40.491936571917755
Free cash flow (dilution-adjusted): 35071000
Buyback yield (%): 1.1708796158517722
Retained earnings: 512543000
Inventory turnover: 1.456117324460055
Receivables turnover: 7.185174064478493
Capitalized R&D asset: 233959110
ROCI (R&D-adjusted, %): 8.028574450366524
Rosenberg metric: -0.8549665917963907
FCF margin (%): 4.187347098133
Revenue growth (%): -16.752278623184804
Rule of 40 score: -12.564931525051804
Financial ratios for CGNX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.95
Shares outstanding: 166419451
Market cap (USD): 6648457067.450001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.44
Shares outstanding: 166419451
Market cap (USD): 5897905343.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGNX — annual report dated 2024-12-31
Total revenue: 914515000
Gross profit: 625794000
Operating income: 115065000
Net income: 106171000
Capital expenditures: 15043000
Operating cash flow: 149081000
Depreciation & amortization: 32689000
Net tangible assets: 1041884000
Owner earnings: 123817000
Return on net tangible assets (%): 11.883952532143693
Capex to operating income (%): 13.073480206839614
Buffett classification: The Great
Stock price: 35.44
P/E ratio: 55.55100115323393
Shares outstanding: 166419451
Book value: 1517505000
P/B ratio: 3.8865805011779204
Market cap (USD): 5897905343.44
Debt to equity: 0.04627134671714426
Current ratio: 3.621248081237454
Quick ratio: 2.691226827252332
Effective tax rate (%): 19.254842610408478
COGS to revenue (%): 31.570941974707907
R&D to revenue (%): 15.28843157301958
SG&A to revenue (%): 40.55854742677813
Free cash flow (dilution-adjusted): 81595000
Buyback yield (%): 1.137437718877871
Retained earnings: 499303000
Inventory turnover: 1.8328350060624528
Receivables turnover: 6.246089854795306
Capitalized R&D asset: 279786890
ROCI (R&D-adjusted, %): 5.456489910749799
Rosenberg metric: 0.17613342898134865
FCF margin (%): 8.922215600618907
Revenue growth (%): 9.18969323512591
Rule of 40 score: 18.111908835744817
Financial ratios for CGNX — quarterly report dated 2025-03-31
Total revenue: 216036000
Gross profit: 144323000
Operating income: 26092000
Net income: 23603000
Capital expenditures: 2501000
Operating cash flow: 40502000
Depreciation & amortization: 7934000
Net tangible assets: 964565000
Owner earnings: 29036000
Return on net tangible assets (%): 3.0102688776806126
Capex to operating income (%): 9.585313506055495
Buffett classification: The Great
Stock price: 29.55
P/E ratio: 52.08760302768715
Shares outstanding: 166419451
Book value: 1445628000
P/B ratio: 3.401770564107779
Market cap (USD): 4917694777.05
Debt to equity: 0.05098268710899346
Current ratio: 3.1401741645104475
Quick ratio: 2.313311300036964
Effective tax rate (%): 15.091013741995827
COGS to revenue (%): 33.19493047455054
R&D to revenue (%): 16.07463570886334
SG&A to revenue (%): 38.65281712307208
Free cash flow (dilution-adjusted): 28062000
Buyback yield (%): 2.0788805453543615
Retained earnings: 405949000
Inventory turnover: 0.4714455700696193
Receivables turnover: 1.3177747956569477
Capitalized R&D asset: 34727000
ROCI (R&D-adjusted, %): 2.7614126738990894
FCF margin (%): 12.989501749708381
Rule of 40 score: 12.989501749708381
Financial ratios for CGNX — quarterly report dated 2025-06-30
Total revenue: 249093000
Gross profit: 167876000
Operating income: 43433000
Net income: 40511000
Capital expenditures: 2194000
Operating cash flow: 42625000
Depreciation & amortization: 7999000
Net tangible assets: 1016533000
Owner earnings: 46316000
Return on net tangible assets (%): 4.556271168766779
Capex to operating income (%): 5.051458568369672
Buffett classification: The Great
Stock price: 31.5
P/E ratio: 81.76393153601397
Shares outstanding: 166419451
Book value: 1506057000
P/B ratio: 3.480753189620313
Market cap (USD): 5242212706.5
Debt to equity: 0.05523363325558063
Current ratio: 3.2857322894185477
Quick ratio: 2.5265468370117152
Effective tax rate (%): 15.71095668095377
COGS to revenue (%): 32.60509127113166
R&D to revenue (%): 13.289012537486
SG&A to revenue (%): 36.66943671640713
Free cash flow (dilution-adjusted): 28137000
Buyback yield (%): 0
Retained earnings: 433040000
Inventory turnover: 0.5617560192838418
Receivables turnover: 1.3383318468531393
Capitalized R&D asset: 56369090
ROCI (R&D-adjusted, %): 2.884520436361741
Rosenberg metric: 0.6782330751288622
FCF margin (%): 11.295781093808337
Revenue growth (%): 15.301616397267123
Rule of 40 score: 26.597397491075462
Financial ratios for CGNX — quarterly report dated 2025-09-30
Total revenue: 276892000
Gross profit: 187290000
Operating income: 57765000
Net income: 17664000
Capital expenditures: 1452000
Operating cash flow: 87485000
Depreciation & amortization: 7533000
Net tangible assets: 1010801000
Owner earnings: 23745000
Return on net tangible assets (%): 2.3491270784259215
Capex to operating income (%): 2.513632822643469
Buffett classification: The Great
Stock price: 45.07
P/E ratio: 91.71812292511433
Shares outstanding: 166419451
Book value: 1489636000
P/B ratio: 5.0351392263412
Market cap (USD): 7500524656.57
Debt to equity: 0.05298274209269915
Current ratio: 3.9635322821714034
Quick ratio: 3.1147318237403483
Effective tax rate (%): 71.90080015271305
COGS to revenue (%): 32.359909278707946
R&D to revenue (%): 12.669560695144677
SG&A to revenue (%): 34.10860552128628
Free cash flow (dilution-adjusted): 73617000
Buyback yield (%): 0.31997761621885307
Retained earnings: 412347000
Inventory turnover: 0.6236262780225363
Receivables turnover: 1.6143329388238175
Capitalized R&D asset: 68719250
ROCI (R&D-adjusted, %): 3.077635478813854
Rosenberg metric: 0.5864902422814331
FCF margin (%): 26.5869003077012
Revenue growth (%): 11.160088802174288
Rule of 40 score: 37.746989109875486
Financial ratios for CGNX — quarterly report dated 2025-12-31
Total revenue: 252338000
Gross profit: 165904000
Operating income: 35276000
Net income: 32664000
Capital expenditures: 4108000
Operating cash flow: 74902000
Depreciation & amortization: 7327000
Net tangible assets: 1024522000
Owner earnings: 35883000
Return on net tangible assets (%): 3.502413808585857
Capex to operating income (%): 11.645311259780021
Buffett classification: The Great
Stock price: 35.88
P/E ratio: 52.176035912339884
Shares outstanding: 166419451
Book value: 1491901000
P/B ratio: 4.00236336183165
Market cap (USD): 5971129901.88
Debt to equity: 0.05133450543970411
Current ratio: 3.7986499664943256
Quick ratio: 3.0474200630887327
Effective tax rate (%): 25.896685496494932
COGS to revenue (%): 34.25326347993564
R&D to revenue (%): 14.290356585215068
SG&A to revenue (%): 37.476717735735406
Free cash flow (dilution-adjusted): 58438000
Buyback yield (%): 0.41868122802233443
Retained earnings: 406355000
Inventory turnover: 0.6268375287368826
Receivables turnover: 1.5415320141973083
Capitalized R&D asset: 70487930
ROCI (R&D-adjusted, %): 1.9221690807658602
Rosenberg metric: -0.6096177417975542
FCF margin (%): 23.158620580332727
Revenue growth (%): -8.867717377172326
Rule of 40 score: 14.2909032031604
Financial ratios for CGNX — annual report dated 2025-12-31
Total revenue: 994359000
Gross profit: 665393000
Operating income: 162566000
Net income: 114442000
Capital expenditures: 2039000
Operating cash flow: 245514000
Depreciation & amortization: 30793000
Net tangible assets: 1024522000
Owner earnings: 143196000
Return on net tangible assets (%): 13.976859452505655
Capex to operating income (%): 1.2542598083240037
Buffett classification: The Great
Stock price: 35.88
P/E ratio: 52.176035912339884
Shares outstanding: 166419451
Book value: 1491901000
P/B ratio: 4.00236336183165
Market cap (USD): 5971129901.88
Debt to equity: 0.05133450543970411
Current ratio: 3.7986499664943256
Quick ratio: 3.0474200630887327
Effective tax rate (%): 37.39565212634435
COGS to revenue (%): 33.08322245788493
R&D to revenue (%): 13.975837700468341
SG&A to revenue (%): 36.59211612707281
Free cash flow (dilution-adjusted): 188254000
Buyback yield (%): 2.5327367263000684
Retained earnings: 406355000
Inventory turnover: 2.3857305513855347
Receivables turnover: 6.074535868974238
Capitalized R&D asset: 278648050
ROCI (R&D-adjusted, %): 7.678395690236941
Rosenberg metric: 0.28322426063011835
FCF margin (%): 18.93219652057255
Revenue growth (%): 8.730747992105105
Rule of 40 score: 27.662944512677655
Financial ratios for CGTX — annual report dated 2021-12-31
Capital expenditures: 27000
Buffett classification: The Gruesome
Stock price: 6.32
Shares outstanding: 89498015
Market cap (USD): 565627454.8000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGTX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -21334000
Net income: -21397000
Capital expenditures: 171000
Operating cash flow: -18533000
Depreciation & amortization: 235000
Net tangible assets: 40249000
Owner earnings: -21333000
Return on net tangible assets (%): -53.00255906979056
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 89498015
Book value: 40249000
P/B ratio: 4.669577666525877
Market cap (USD): 187945831.5
Debt to equity: 0.03672140922755845
Current ratio: 6.112508017960231
Quick ratio: 6.112508017960231
Interest coverage ratio: -761.9285714285714
Free cash flow (dilution-adjusted): -22276000
Buyback yield (%): 0
Retained earnings: -115401000
Receivables turnover: 0
Capitalized R&D asset: 30324000
ROCI (R&D-adjusted, %): -1.5324725169284756
Rule of 40 score: 0
Financial ratios for CGTX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -25919000
Net income: -25788000
Capital expenditures: 147000
Operating cash flow: -16018000
Depreciation & amortization: 252000
Net tangible assets: 24474000
Owner earnings: -25683000
Return on net tangible assets (%): -104.93993625888697
Buffett classification: The Gruesome
Stock price: 1.85
Shares outstanding: 89498015
Book value: 24474000
P/B ratio: 6.7651927657922695
Market cap (USD): 165571327.75
Debt to equity: 0.05058429353599739
Current ratio: 3.36532599075622
Quick ratio: 3.36532599075622
Interest coverage ratio: -959.9629629629629
Free cash flow (dilution-adjusted): -20519000
Buyback yield (%): 0
Retained earnings: -141189000
Receivables turnover: 0
Capitalized R&D asset: 57513080
ROCI (R&D-adjusted, %): -13.610549139136504
Rule of 40 score: 0
Financial ratios for CGTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.47
Shares outstanding: 89498015
Market cap (USD): 42064067.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGTX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -34417000
Net income: -33971000
Capital expenditures: 4000
Operating cash flow: -28474000
Depreciation & amortization: 266000
Net tangible assets: 18750000
Owner earnings: -33709000
Return on net tangible assets (%): -179.78133333333332
Buffett classification: The Gruesome
Stock price: 0.7
Shares outstanding: 89498015
Book value: 18750000
P/B ratio: 3.3412592266666663
Market cap (USD): 62648610.49999999
Debt to equity: 0.04341333333333333
Current ratio: 2.6525758391671155
Quick ratio: 2.6525758391671155
Interest coverage ratio: -1376.68
Free cash flow (dilution-adjusted): -32226000
Buyback yield (%): 0
Retained earnings: -175160000
Receivables turnover: 0
Capitalized R&D asset: 76604240
ROCI (R&D-adjusted, %): -30.450168853725774
Rule of 40 score: 0
Financial ratios for CGTX — quarterly report dated 2024-12-31
Capital expenditures: 1000
Buffett classification: The Gruesome
Stock price: 0.7
Shares outstanding: 89498015
Market cap (USD): 62648610.49999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGTX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -8689000
Net income: -8480000
Capital expenditures: 0
Operating cash flow: -9877000
Depreciation & amortization: 45000
Net tangible assets: 12270000
Owner earnings: -8435000
Return on net tangible assets (%): -68.74490627546862
Buffett classification: The Gruesome
Stock price: 0.42
Shares outstanding: 89498015
Book value: 12270000
P/B ratio: 3.06350173594132
Market cap (USD): 37589166.3
Debt to equity: 0.05175224123879381
Current ratio: 2.0882191780821917
Quick ratio: 2.0882191780821917
Interest coverage ratio: -1737.8
Free cash flow (dilution-adjusted): -10463000
Buyback yield (%): 0
Retained earnings: -183640000
Receivables turnover: 0
Capitalized R&D asset: 10786000
ROCI (R&D-adjusted, %): -6.420694777739687
Rule of 40 score: 0
Financial ratios for CGTX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -6872000
Net income: -6734000
Capital expenditures: 0
Operating cash flow: -5623000
Depreciation & amortization: 61000
Net tangible assets: 7029000
Owner earnings: -6673000
Return on net tangible assets (%): -94.93526817470479
Buffett classification: The Gruesome
Stock price: 0.31
Shares outstanding: 89498015
Book value: 7029000
P/B ratio: 3.947131121069853
Market cap (USD): 27744384.65
Debt to equity: 0.06658130601792574
Current ratio: 1.5406826269815594
Quick ratio: 1.5406826269815594
Interest coverage ratio: -2290.6666666666665
Free cash flow (dilution-adjusted): -6244000
Buyback yield (%): 0
Retained earnings: -190374000
Receivables turnover: 0
Capitalized R&D asset: 18707620
ROCI (R&D-adjusted, %): -10.834839812541865
Rule of 40 score: 0
Financial ratios for CGTX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -5160000
Net income: -4930000
Capital expenditures: 0
Operating cash flow: -5651000
Depreciation & amortization: 61000
Net tangible assets: 36529000
Owner earnings: -4869000
Return on net tangible assets (%): -13.32913575515344
Buffett classification: The Gruesome
Stock price: 1.35
Shares outstanding: 89498015
Book value: 36529000
P/B ratio: 3.307572620383805
Market cap (USD): 120822320.25000001
Debt to equity: 0.010402693750171096
Current ratio: 6.444694920348662
Quick ratio: 6.444694920348662
Free cash flow (dilution-adjusted): -6173000
Buyback yield (%): 0
Retained earnings: -195304000
Receivables turnover: 0
Capitalized R&D asset: 15024650
ROCI (R&D-adjusted, %): -19.447258944879472
Rule of 40 score: 0
Financial ratios for CGTX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -3672000
Net income: -3343000
Capital expenditures: 9000
Operating cash flow: -3437000
Depreciation & amortization: 61000
Net tangible assets: 34271000
Owner earnings: -3291000
Return on net tangible assets (%): -9.602871232237169
Buffett classification: The Gruesome
Stock price: 1.35
Shares outstanding: 89498015
Book value: 34271000
P/B ratio: 3.525497366578157
Market cap (USD): 120822320.25000001
Debt to equity: 0.018616322838551545
Current ratio: 3.446638896868716
Quick ratio: 3.446638896868716
Interest coverage ratio: -734.4
Free cash flow (dilution-adjusted): -3795000
Buyback yield (%): 0
Retained earnings: -198647000
Receivables turnover: 0
Capitalized R&D asset: 17463640
ROCI (R&D-adjusted, %): -2.5521712327166797
Rule of 40 score: 0
Financial ratios for CGTX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -24393000
Net income: -23487000
Capital expenditures: 9000
Operating cash flow: -24588000
Depreciation & amortization: 228000
Net tangible assets: 34271000
Owner earnings: -23268000
Return on net tangible assets (%): -67.89413790084912
Buffett classification: The Gruesome
Stock price: 1.35
Shares outstanding: 89498015
Book value: 34271000
P/B ratio: 3.525497366578157
Market cap (USD): 120822320.25000001
Debt to equity: 0.018616322838551545
Current ratio: 3.446638896868716
Quick ratio: 3.446638896868716
Interest coverage ratio: -1876.3846153846155
Free cash flow (dilution-adjusted): -26675000
Buyback yield (%): 0
Retained earnings: -198647000
Receivables turnover: 0
Capitalized R&D asset: 77384600
ROCI (R&D-adjusted, %): -23.149033919651156
Rule of 40 score: 0
Financial ratios for CIGI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 146.87
Shares outstanding: 49778127
Market cap (USD): 7310913512.49
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIGI — annual report dated 2022-12-31
Total revenue: 3279034558.8235292
Gross profit: 1257354411.764706
Operating income: 320936764.7058823
Net income: 143047058.8235294
Capital expenditures: 49765441.176470585
Operating cash flow: 49287500
Depreciation & amortization: 130456617.64705881
Net tangible assets: -1954964705.8823528
Owner earnings: 223738235.29411763
Return on net tangible assets (%): -11.44461762511133
Capex to operating income (%): 15.506307363096084
Buffett classification: The Great
Stock price: 91.22
P/E ratio: 31.743125530051817
Shares outstanding: 49778127
Book value: 1156382352.9411764
P/B ratio: 3.9266949494610475
Market cap (USD): 4540760744.94
Debt to equity: 1.3336495663453467
Current ratio: 0.9044739717736224
Quick ratio: 0.9044739717736224
Effective tax rate (%): 32.812532377380386
Interest coverage ratio: 8.983349455615699
COGS to revenue (%): 61.654737417106496
SG&A to revenue (%): 24.579217295621667
Free cash flow (dilution-adjusted): -16546323.529411765
Buyback yield (%): 2.6836653674212023
Retained earnings: -282499264.7058823
Receivables turnover: 5.983045640058281
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.618872942119125
FCF margin (%): -0.5046096109260999
Rule of 40 score: -0.5046096109260999
Financial ratios for CIGI — annual report dated 2023-12-31
Total revenue: 3284197727.272727
Gross profit: 1316907575.7575758
Operating income: 265388636.36363634
Net income: 109614393.93939394
Capital expenditures: 64033333.33333333
Operating cash flow: 125500757.57575756
Depreciation & amortization: 153436363.63636363
Net tangible assets: -1720242424.2424242
Owner earnings: 199017424.24242425
Return on net tangible assets (%): -11.569149873167982
Capex to operating income (%): 24.128136837628062
Buffett classification: The Great
Stock price: 125.73
P/E ratio: 57.09655167340886
Shares outstanding: 49778127
Book value: 1456481818.181818
P/B ratio: 4.2970697124958654
Market cap (USD): 6258603907.71
Debt to equity: 1.1114427876223112
Current ratio: 1.0229327656633682
Quick ratio: 1.0229327656633682
Effective tax rate (%): 31.998759264394177
Interest coverage ratio: 3.7236837909372107
COGS to revenue (%): 59.90169639234342
SG&A to revenue (%): 27.345569613537368
Free cash flow (dilution-adjusted): 40946969.6969697
Buyback yield (%): 0
Retained earnings: -252171212.1212121
Receivables turnover: 4.3883941631700685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.66915471825303
FCF margin (%): 1.2467875900691583
Revenue growth (%): 0.15746001930062734
Rule of 40 score: 1.4042476093697855
Financial ratios for CIGI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 151.07
Shares outstanding: 49778127
Market cap (USD): 7519981645.889999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIGI — annual report dated 2024-12-31
Total revenue: 3372044755.2447553
Gross profit: 1344108391.6083918
Operating income: 252734265.73426574
Net income: 165689510.4895105
Capital expenditures: 45513986.013986014
Operating cash flow: 227978321.6783217
Depreciation & amortization: 154966433.56643358
Net tangible assets: -1508154545.4545455
Owner earnings: 275141958.0419581
Return on net tangible assets (%): -18.24361825989342
Capex to operating income (%): 18.00863285465261
Buffett classification: The Great
Stock price: 135.46
P/E ratio: 40.6962701712302
Shares outstanding: 49778127
Book value: 1733006993.0069933
P/B ratio: 3.8908931762128156
Market cap (USD): 6742945083.42
Debt to equity: 0.830436607214914
Current ratio: 1.0605706343527794
Quick ratio: 1.0605706343527794
Effective tax rate (%): 23.842462385049807
Interest coverage ratio: 4.2132689819186515
COGS to revenue (%): 60.1396633446868
SG&A to revenue (%): 27.76972905983048
Free cash flow (dilution-adjusted): 150267832.16783217
Buyback yield (%): 0
Retained earnings: -130260839.16083917
Receivables turnover: 4.830385397122419
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.869439721846737
FCF margin (%): 4.456282258238449
Revenue growth (%): 2.674839801590705
Rule of 40 score: 7.1311220598291545
Financial ratios for CIGI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 135.46
Shares outstanding: 49778127
Market cap (USD): 6742945083.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIGI — quarterly report dated 2025-03-31
Total revenue: 798020979.020979
Gross profit: 316559440.55944055
Operating income: 28660839.160839163
Net income: 6236363.636363637
Capital expenditures: 10247552.447552448
Operating cash flow: -59074125.874125876
Depreciation & amortization: 44337062.93706294
Net tangible assets: -1497845454.5454545
Owner earnings: 40325874.125874124
Return on net tangible assets (%): -2.6922586708460967
Capex to operating income (%): 35.75454434549225
Buffett classification: The Good
Stock price: 120.84
P/E ratio: 241.13366448061223
Shares outstanding: 49778127
Book value: 1746993006.9930072
P/B ratio: 3.443167112061644
Market cap (USD): 6015188866.68
Debt to equity: 0.8923925226162837
Current ratio: 1.174732199071214
Quick ratio: 1.174732199071214
Effective tax rate (%): 34.57079970652972
Interest coverage ratio: 1.8176778428241973
COGS to revenue (%): 60.33194002646407
SG&A to revenue (%): 30.5206936740363
Free cash flow (dilution-adjusted): -73973426.57342657
Buyback yield (%): 0
Retained earnings: -133239160.83916084
Receivables turnover: 1.2275806279844537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8608762264361783
FCF margin (%): -9.269609260671066
Rule of 40 score: -9.269609260671066
Financial ratios for CIGI — quarterly report dated 2025-06-30
Total revenue: 983685401.4598539
Gross profit: 401156934.30656934
Operating income: 84118248.17518248
Net income: 46694160.5839416
Capital expenditures: 11991240.875912407
Operating cash flow: 32527737.22627737
Depreciation & amortization: 45026277.37226277
Net tangible assets: -1597221167.8832116
Owner earnings: 79729197.08029196
Return on net tangible assets (%): -4.991744329682071
Capex to operating income (%): 14.255219451241736
Buffett classification: The Great
Stock price: 130.2
P/E ratio: 122.44564418868369
Shares outstanding: 49778127
Book value: 1856773722.6277375
P/B ratio: 3.4905234043423556
Market cap (USD): 6481112135.4
Debt to equity: 0.9127707584775412
Current ratio: 1.1740674025226627
Quick ratio: 1.1740674025226627
Effective tax rate (%): 28.29569018662781
Interest coverage ratio: 7.4277795681598455
COGS to revenue (%): 59.21898060993628
SG&A to revenue (%): 27.652378326997606
Free cash flow (dilution-adjusted): 13855474.452554742
Buyback yield (%): 0
Retained earnings: -141710948.90510947
Receivables turnover: 1.2667743266628628
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3091946793262736
FCF margin (%): 1.4085269977568342
Revenue growth (%): 23.265606709569216
Rule of 40 score: 24.67413370732605
Financial ratios for CIGI — quarterly report dated 2025-09-30
Total revenue: 1052588489.2086332
Gross profit: 413407913.66906476
Operating income: 74776978.41726619
Net income: 46858992.8057554
Capital expenditures: 12067625.899280576
Operating cash flow: 81553956.83453238
Depreciation & amortization: 46334532.37410072
Net tangible assets: -1746616546.7625902
Owner earnings: 81125899.28057554
Return on net tangible assets (%): -4.644745833362509
Capex to operating income (%): 16.138156628824323
Buffett classification: The Great
Stock price: 155.8
P/E ratio: 77.71790482335557
Shares outstanding: 49778127
Book value: 1956261870.5035977
P/B ratio: 3.964414122432152
Market cap (USD): 7755432186.6
Debt to equity: 0.9206944385195077
Current ratio: 1.1395431632412734
Quick ratio: 1.1395431632412734
Effective tax rate (%): 22.693284591829467
Interest coverage ratio: 4.578854625550661
COGS to revenue (%): 60.72464045470638
SG&A to revenue (%): 27.769295016465062
Free cash flow (dilution-adjusted): 56351798.56115108
Buyback yield (%): 0
Retained earnings: -109287769.78417267
Receivables turnover: 1.2294548577440383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0133792674623456
FCF margin (%): 5.353640015911442
Revenue growth (%): 7.0045857798156375
Rule of 40 score: 12.35822579572708
Financial ratios for CIGI — annual report dated 2025-12-31
Total revenue: 4057271532.846715
Gross profit: 1624876642.3357663
Operating income: 293084671.5328467
Net income: 163907299.27007297
Capital expenditures: 57446715.328467146
Operating cash flow: 240978102.189781
Depreciation & amortization: 186872262.77372262
Net tangible assets: -1694737226.2773721
Owner earnings: 293332846.71532845
Return on net tangible assets (%): -17.30845597577731
Capex to operating income (%): 19.60072324083621
Buffett classification: The Great
Stock price: 146.77
P/E ratio: 44.57358355805668
Shares outstanding: 49778127
Book value: 2058021167.8832111
P/B ratio: 3.5499808329496245
Market cap (USD): 7305935699.790001
Debt to equity: 0.8106660462232697
Current ratio: 1.1009019635806372
Quick ratio: 1.1009019635806372
Effective tax rate (%): 26.305270308854077
Interest coverage ratio: 4.8744855717286
COGS to revenue (%): 59.951493776515875
SG&A to revenue (%): 28.218956970471325
Free cash flow (dilution-adjusted): 142932116.78832114
Buyback yield (%): 0
Retained earnings: -71869343.06569342
Receivables turnover: 4.586995899444374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.8214784734319736
FCF margin (%): 3.5228629790039037
Revenue growth (%): 20.32080910362127
Rule of 40 score: 23.843672082625172
Financial ratios for CIGI — quarterly report dated 2025-12-31
Total revenue: 1172660583.9416058
Gross profit: 473853284.6715328
Operating income: 103181751.82481751
Net income: 63160583.941605836
Capital expenditures: 22515328.467153285
Operating cash flow: 187367153.28467152
Depreciation & amortization: 48556204.37956204
Net tangible assets: -1694737226.2773721
Owner earnings: 89201459.8540146
Return on net tangible assets (%): -5.263438984576556
Capex to operating income (%): 21.821037217297803
Buffett classification: The Great
Stock price: 146.77
P/E ratio: 44.83541683254119
Shares outstanding: 49778127
Book value: 2058021167.8832111
P/B ratio: 3.5499808329496245
Market cap (USD): 7305935699.790001
Debt to equity: 0.8106660462232697
Current ratio: 1.1009019635806372
Quick ratio: 1.1009019635806372
Effective tax rate (%): 26.425073124277258
Interest coverage ratio: 6.541369736233225
COGS to revenue (%): 59.59160807820509
SG&A to revenue (%): 27.468760601165854
Free cash flow (dilution-adjusted): 149115328.46715328
Buyback yield (%): 0
Retained earnings: -71869343.06569342
Receivables turnover: 1.32576517160194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7535860081934183
FCF margin (%): 12.715983679262019
Revenue growth (%): 11.407315960983606
Rule of 40 score: 24.123299640245627
Financial ratios for CRNA.OL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.559863169897377
Shares outstanding: 274440710
Market cap (USD): 2074734215.8494868
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNA.OL — annual report dated 2022-12-31
Total revenue: 1012348.1781376518
Operating income: -49958603.238866396
Net income: -43815587.04453441
Capital expenditures: 499493.92712550604
Operating cash flow: -11016295.546558704
Depreciation & amortization: 39744230.76923077
Net tangible assets: 257591.0931174089
Owner earnings: -4570850.202429146
Return on net tangible assets (%): -1774.4597249508824
Buffett classification: The Gruesome
Stock price: 3.327935222672065
Shares outstanding: 274440710
Book value: 259716.59919028357
P/B ratio: 3516.605824162118
Market cap (USD): 913320905.3441296
Debt to equity: 24.715120810600137
Current ratio: 2.328640356303353
Quick ratio: 2.328640356303353
Interest coverage ratio: -98.836804164998
COGS to revenue (%): 0
R&D to revenue (%): 472.1855628874225
SG&A to revenue (%): 50.189962007598474
Free cash flow (dilution-adjusted): -11939271.255060727
Buyback yield (%): 0
Retained earnings: -12517408.90688259
Receivables turnover: 1.6003200000000002
Capitalized R&D asset: 4780161.943319838
ROCI (R&D-adjusted, %): -430.96017483158784
FCF margin (%): -1179.3641271745648
Rule of 40 score: -1179.3641271745648
Financial ratios for CRNA.OL — annual report dated 2023-12-31
Total revenue: 12082.514734774068
Operating income: -9819744.59724951
Net income: -11094400.785854617
Capital expenditures: 289489.19449901767
Operating cash flow: -8761886.051080551
Depreciation & amortization: 174165.02946954814
Net tangible assets: -9681237.721021611
Owner earnings: -11209724.950884087
Buffett classification: The Gruesome
Stock price: 0.7072691552062869
Shares outstanding: 274440710
Book value: -9679960.707269154
Market cap (USD): 194103449.11591357
Debt to equity: -1.1206795072151976
Current ratio: 0.20681995605739903
Quick ratio: 0.20681995605739903
Interest coverage ratio: -28.103739105988193
COGS to revenue (%): 0
R&D to revenue (%): 40560.9756097561
SG&A to revenue (%): 3930.0813008130076
Free cash flow (dilution-adjusted): -8930451.866404716
Buyback yield (%): 0
Retained earnings: -13993418.467583498
Receivables turnover: 1.138888888888889
Capitalized R&D asset: 8103494.356641188
FCF margin (%): -73912.19512195123
Revenue growth (%): -98.80648624695493
Rule of 40 score: -74011.00160819819
Financial ratios for CRNA.OL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -3750661.9593998236
Net income: 5077052.074139453
Capital expenditures: 16681.376875551632
Operating cash flow: -3577405.119152692
Depreciation & amortization: 1147.396293027361
Net tangible assets: -1104589.5851721095
Owner earnings: 5061518.093556928
Return on net tangible assets (%): -458.22612864562524
Buffett classification: The Gruesome
Stock price: 0.06261022927689594
P/E ratio: 3.38440408431827
Shares outstanding: 274440710
Book value: -1104148.2789055603
Market cap (USD): 17182795.77601411
Debt to equity: -1.3873701039168667
Current ratio: 0.6301581292408049
Quick ratio: 0.6301581292408049
Effective tax rate (%): 0
Interest coverage ratio: -2124.75
Free cash flow (dilution-adjusted): -3677934.6866725506
Buyback yield (%): 0
Retained earnings: -4814474.845542807
Capitalized R&D asset: 5892577.492573774
ROCI (R&D-adjusted, %): -131.3540757836581
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CRNA.OL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1104589.5851721095
Buffett classification: The Gruesome
Stock price: 0.06261022927689594
Shares outstanding: 274440710
Book value: -1104148.2789055603
Market cap (USD): 17182795.77601411
Debt to equity: -1.3873701039168667
Current ratio: 0.6301581292408049
Quick ratio: 0.6301581292408049
Buyback yield (%): 0
Retained earnings: -4814474.845542807
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRNA.OL — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1231678.2522343595
Buffett classification: The Gruesome
Stock price: 0.06454816285998013
Shares outstanding: 274440710
Book value: -1231578.947368421
Market cap (USD): 17714643.64448858
Debt to equity: -0.8959038864699244
Current ratio: 0.49968190854870775
Quick ratio: 0.49968190854870775
Buyback yield (%): 0
Retained earnings: -7645084.409136048
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CUE.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03007518796992481
Shares outstanding: 703170743
Market cap (USD): 21147992.27067669
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0